Search Results - "Gershanik, Oscar S."
-
1
Improving l-dopa therapy: The development of enzyme inhibitors
Published in Movement disorders (01-01-2015)“…ABSTRACT The introduction of levodopa produced a monumental change in the treatment of Parkinson's disease (PD). Limitations in its bioavailability and…”
Get full text
Journal Article -
2
Postural deformities in Parkinson's disease
Published in Lancet neurology (01-06-2011)“…Summary Postural deformities are frequent and disabling complications of Parkinson's disease (PD) and atypical parkinsonism. These deformities include…”
Get full text
Journal Article -
3
Does Parkinson's disease start in the gut?
Published in Arquivos de neuro-psiquiatria (01-02-2018)“…Current understanding of the pathophysiology of Parkinson's disease suggests a key role of the accumulation of alpha-synuclein in the pathogenesis. This…”
Get full text
Journal Article -
4
Screening for idiopathic REM sleep behavior disorder: usefulness of actigraphy
Published in Sleep (New York, N.Y.) (01-06-2018)“…Abstract Study Objectives To evaluate the utility of multimodal low-cost approaches including actigraphy, a wrist-worn device monitoring rest/activity cycles,…”
Get full text
Journal Article -
5
Past, present, and future of Parkinson's disease
Published in Movement disorders (01-09-2017)Get full text
Journal Article -
6
Unanswered Questions in Clinical Practice
Published in Movement disorders clinical practice (Hoboken, N.J.) (01-08-2023)Get full text
Journal Article -
7
Cabergoline and pramipexole fail to modify already established dyskinesias in an animal model of parkinsonism
Published in Behavioural brain research (01-12-2008)“…Levodopa-induced dyskinesias are one of the major limiting side effects encountered in the treatment of Parkinson's disease. Dopamine agonists of the D2 family…”
Get full text
Journal Article -
8
Pleiotrophin over-expression provides trophic support to dopaminergic neurons in parkinsonian rats
Published in Molecular neurodegeneration (07-06-2011)“…Pleiotrophin is known to promote the survival and differentiation of dopaminergic neurons in vitro and is up-regulated in the substantia nigra of Parkinson's…”
Get full text
Journal Article -
9
Dancing Dorsal Quadrilaterals: A Novel Peripherally Induced Movement Disorder
Published in JAMA neurology (01-03-2019)“…Recognized peripherally induced movement disorders include the painful legs moving toes syndrome, postamputation dyskinesias, and belly dancer dyskinesias. To…”
Get more information
Journal Article -
10
Clinical problems in late-stage Parkinson’s disease
Published in Journal of neurology (01-11-2010)“…Advanced Parkinson’s disease patients require for their care the participation of a multidisciplinary team. Particularly in the late stages of the disease,…”
Get full text
Journal Article -
11
Subjective visual vertical in Pisa syndrome
Published in Parkinsonism & related disorders (01-08-2014)“…Abstract Background Parkinson's Disease (PD) alters perception and somatosensory information integration, including visual dependency and judgment of body…”
Get full text
Journal Article -
12
The Kinase Fyn As a Novel Intermediate in l-DOPA-Induced Dyskinesia in Parkinson’s Disease
Published in Molecular neurobiology (01-06-2018)“…Dopamine replacement therapy with l -DOPA is the treatment of choice for Parkinson’s disease; however, its long-term use is frequently associated with l…”
Get full text
Journal Article -
13
Regulation of Pleiotrophin and Fyn in the striatum of rats undergoing L-DOPA-induced dyskinesia
Published in Neuroscience letters (14-02-2018)“…•Striatal Pleiotrophin immunodetection is increased in L-DOPA induced dyskinesias.•Total amounts of the kinase Fyn are unchanged by 6-OHDA lesion or…”
Get full text
Journal Article -
14
Stiff-person syndrome
Published in Parkinsonism & related disorders (01-12-2009)Get full text
Journal Article -
15
Contrasting gene expression patterns induced by levodopa and pramipexole treatments in the rat model of Parkinson's disease
Published in Neuropharmacology (01-02-2016)“…Whether the treatment of Parkinson's disease has to be initiated with levodopa or a D2 agonist like pramipexole remains debatable. Levodopa is more potent…”
Get full text
Journal Article -
16
Highlights of the Stockholm Congress: A Clinician's Perspective
Published in Movement disorders clinical practice (Hoboken, N.J.) (01-12-2014)Get full text
Journal Article -
17
Effects of orally administered levodopa on mesencephalic dopaminergic neurons undergoing a degenerative process
Published in Neuroscience research (01-12-2003)“…Although the issue of in vivo levodopa toxicity appears to be settled by now in the light of recent findings, a crucial aspect was not accounted for the…”
Get full text
Journal Article -
18
A Functional Parkinsonian Tremor in a Pediatric Patient
Published in Movement disorders clinical practice (Hoboken, N.J.) (01-03-2017)“…View Supplementary Video 1…”
Get full text
Journal Article -
19
Typical and atypical neuroleptics
Published in Handbook of clinical neurology (2011)“…Neuroleptics having dopamine receptor-blocking properties are frequently responsible for the development of movement disorders. This has been known for many…”
Get more information
Journal Article -
20
Mapping the Effects of Three Dopamine Agonists with Different Dyskinetogenic Potential and Receptor Selectivity Using Pharmacological Functional Magnetic Resonance Imaging
Published in Neuropsychopharmacology (New York, N.Y.) (01-09-2007)“…The mechanisms underlying dopamine agonist-induced dyskinesia in Parkinson's disease remain poorly understood. Similar to patients, rats with severe…”
Get full text
Journal Article